This page features ACC's full meeting coverage of the latest science from ACC.25 – including trial summaries, news stories, journal scans, videos and more.

This page features ACC's full coverage of the latest science from American Heart Association's (AHA) Scientific Sessions 2025, taking place Nov. 7–10 in New Orleans, LA.

Semaglutide, the popular anti-obesity medication originally developed to treat diabetes, continues to show cardiovascular benefits beyond weight loss, including reducing risk of death, reducing ...

In-hospital initiation of dapagliflozin in patients hospitalized for acute heart failure (HF) did not significantly reduce the short-term risk of worsening HF or death, based on findings from the DAPA ...

HFpEF accounts for approximately half of all HF cases, yet therapeutic options remain limited. Steroidal mineralocorticoid receptor antagonists (MRAs) like spironolactone and eplerenone have ...

The Young Investigator Awards competition provides young scientific investigators with an opportunity to showcase their cutting-edge research. At ACC.27-WCC, 15 finalists will present their work in ...

YOU ARE HERE: Home > Guidelines and Clinical Policy > 2024 AHA/ACC/AMSSM/HRS/PACES/SCMR Guideline for the Management of Hypertrophic Cardiomyopathy ...

The human physiology of altitude reflects acute and chronic human acclimatization to hypobaric hypoxia. Athletes and active individuals with cardiovascular disease who are asymptomatic and without ...

Previous studies have found less than 40% of patients with stable chest pain undergoing invasive coronary angiography are found to have obstructive coronary artery disease. Recent randomized clinical ...

The following are key points to remember from a review of lipoprotein(a) [Lp(a)] and cardiovascular disease (CVD): ...

The following are key points to remember from the 2022 European Society of Cardiology/European Respiratory Society (ESC/ERS) guidelines for the diagnosis and treatment of pulmonary hypertension: ...

The following are key points to remember from the 2024 European Society of Cardiology (ESC) guidelines for the management of elevated blood pressure (BP) and hypertension: ...